&w=3840&q=100)
Carlyle Group may sell 10% stake in Piramal Pharma via block deals: Report
Piramal Pharma sold 20 per cent of its stake to Carlyle Group in June 2020, in a deal worth ₹3,523 crore. According to stock exchange data, it held 18 per cent stake in the pharma firm as of March 31, 2025.
Financial services firm Motilal Oswal has been roped in to facilitate the block deals, the report added.
Piramal Pharma operates a diverse and global pharmaceutical business, providing a broad range of products and services. It includes Piramal Pharma Solutions (PPS), a fully integrated contract development and manufacturing organisation (CDMO); Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter consumer and wellness products.
Piramal Pharma Q4 result
In the fourth quarter of FY25, Piramal Pharma posted a consolidated revenue from operations of ₹2,754 crore, marking an 8 per cent increase over the ₹2,552 crore recorded in the same quarter last year. The company's EBITDA (earnings before interest, tax, depreciation, and amortisation) also increased by 8 per cent year-on-year to ₹603 crore, up from ₹556 crore. Profit after tax (before exceptional items) came in at ₹154 crore, reflecting a 16 per cent rise compared to ₹132 crore in the corresponding period of the previous financial year.
Shares of Piramal Pharma last traded at ₹202.4 apiece on the BSE at the close of the markets on Thursday.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Wire
11 minutes ago
- The Wire
Marathon Nextgen Realty Raises Rs. 900 Crore Through Qualified Institutions Placement
Overwhelming Response from Premier Domestic and International Institutional Investors Validates Company's Growth Strategy MUMBAI, India, July 4, 2025 /PRNewswire/ -- Marathon Nextgen Realty Ltd (BSE: 503101) (NSE: MARATHON) ("MNRL"), one of Mumbai's leading real estate development companies, has successfully completed a Qualified Institutions Placement (QIP), raising Rs. 900 crore (US$ 105 million). The QIP proceeds will primarily be used as growth capital, enabling the company to expand its development pipeline and invest in high-potential opportunities across the Mumbai Metropolitan Region. This capital infusion will further strengthen the company's financial foundation with its net debt-to-equity ratio expected to reduce further from the current 0.46 following the planned debt reduction. The QIP was executed through the issuance of 1,62,12,406 equity shares at ₹555.13 per share (face value ₹5 each). The offering, which closed on June 30, 2025, attracted strong participation from leading institutional investors including Quant Mutual Fund, Kotak Alternate Asset Managers, and Samco Mutual Fund, among others. This QIP has significantly enhanced MNRL's institutional investor base, with Foreign Institutional Investor (FII) holding increasing to 9.9% and Domestic Institutional Investor (DII) holding rising to 16.66% post-issue. Management Commentary Mr. Chetan Shah, CMD of MNRL, said, "This successful capital raise of Rs. 900 crore represents a decisive vote of confidence from marquee institutional investors in our strategic vision and execution capabilities. The Indian real estate sector is witnessing unprecedented momentum creating substantial opportunities for well-positioned players like MNRL. Our demonstrated track record of delivering projects on time, coupled with our strategic land bank and robust project pipeline, positions us exceptionally well to capitalize on this sector upswing. Additionally, our recently approved amalgamation scheme—bringing promoter group entities and their assets under the MNRL—will consolidate our land bank, projects and inventory, creating an efficient operating structure with better corporate governance. We are at a strategic inflection point, equipped with the right capital, a robust asset base, and a clear long-term vision to drive the next phase of MNRL's evolution." Use of Proceeds The proceeds from the QIP will be utilized strategically across the following areas: Strategic Priority Allocation Percentage Debt Reduction ₹340 crore 38 % Land Acquisition and development rights ₹300 crore 33 % Fund on-going projects ₹160 crore 18 % General Corporate Purposes ₹100 crore 11 % Distinguished Investor Participation The QIP saw participation from a prestigious group of domestic and international institutional investors, including: Domestic Institutional Investors: Foreign Institutional Investors: Quant Mutual Fund Samco Mutual Fund Kotak Alternate Asset Managers SageOne Investment Managers Buoyant Capital Brescon Opportunities Fund Maybank Securities Morgan Stanley Asia Citigroup Global Markets Nomura Singapore Limited North Star Opportunities Fund Zeta Global Funds Eminence Global Fund PCC Necta Bloom VCC The complete Placement Document is available for detailed information About Marathon Group For over 53 years now, Marathon Group has been helping shape Mumbai's skyline. Founded in 1969 by Ramniklal Zaverbhai Shah, the Group has completed over 100 projects in the city with a portfolio encompassing townships, affordable housing, luxury residential, retail, small business spaces, and corporate parks. Marathon is design-driven and engineering-focused with a leadership team comprising of technocrats. Mr. Chetan Shah, Chairman & Mr. Mayur Shah, Vice-Chairman, have completed their engineering from US and the third generation of the company comprising of the three heads of projects –Mr. Kaivalya Shah, Mr. Parmeet Shah, and Mr. Samyag Shah are highly qualified having completed their education from US and bring decades of real estate experience. Marathon has strong in-house capabilities in design, engineering, execution, marketing, and sales, and prides itself on its transparency and customer-centricity. The Group has ongoing projects and land banks at Lower Parel, Byculla, Mulund, Bhandup, Thane, Dombivli and Panvel. More information is available at Disclaimer Some of the statements in this communication may be 'forward-looking statements within the meaning of applicable laws and regulations. Actual results might differ substantially from those expressed or implied. Important developments that could affect the company's operations include changes in the industry structure, significant changes in the political and economic environment in India and overseas, tax laws, duties, litigation, and labour relations. Photo: Logo: (Disclaimer: The above press release comes to you under an arrangement with PRNewswire and PTI takes no editorial responsibility for the same.).
&w=3840&q=100)
Business Standard
12 minutes ago
- Business Standard
Lenskart invests in AI startup Ajna Lens ahead of smart glasses push
Eyewear unicorn Lenskart has invested in AI startup Ajna Lens as it races to develop smart glasses ahead of its planned $1 billion IPO, marking the company's latest move into wearable technology. The investment, whose value was not disclosed by the firms, gives Lenskart access to Ajna Lens's artificial intelligence-powered extended reality (XR) technology, as the Mumbai-based startup specialises in developing advanced wearable tech products. Ajna Lens, recognised with a CES Innovation Award in 2023 for its mixed reality headset AjnaXR, is known for developing some of the most advanced wearable technology in the sector. The partnership comes as the global smart glasses market—valued at over $6 billion and expected to reach $15.08 billion by 2032, growing at a CAGR of 10.3 per cent—faces increasing competition from tech giants such as Meta, Apple, and Google. Lenskart said it plans to combine its capabilities in frame design and optical engineering with Ajna's technology to create smart glasses that are more accessible and aligned with everyday consumer use. The company emphasised that its approach to smart eyewear will prioritise the fundamentals of vision correction and wearability, framing them as 'glasses first' in both form and function. 'This investment marks the next chapter in our smart glass journey, which began with the launch of Phonic, our audio glasses, in December 2024,' said Peyush Bansal, Co-founder and Chief Executive Officer of Lenskart. 'As the smart glasses category scales rapidly, our partnership with Ajna Lens strategically positions us to accelerate product innovation in this space.' Founded in 2014 and headquartered in Thane, Mumbai, Ajna Lens is a deep-tech startup developing immersive technologies powered by spatial computing, AI vision, and an XR stack. The Ajna investment is part of Lenskart's broader acquisition strategy to gain access to new technologies and scale operations. The company has previously acquired firms such as Tango Eye, an artificial intelligence-based computer vision startup. In 2022, Japanese brand Owndays became part of the Lenskart group in a deal estimated at $400 million. In 2023, Neso Brands, a subsidiary of Lenskart, acquired a stake in the Paris-based eyewear brand Le Petit Lunetier for $4 million. Lenskart's aggressive expansion comes as the company prepares for its public market debut. US financial services major Fidelity recently increased its estimated valuation of Lenskart to $6.1 billion, according to its latest monthly portfolio disclosure, up from $5.6 billion in November. The company plans to raise up to $1 billion at a targeted valuation of $10 billion and recently converted its parent entity from a private limited to a public limited company. The company has demonstrated strong financial performance ahead of its IPO. Lenskart's revenue from operations rose by 43 per cent to Rs 5,427.7 crore in FY24 from Rs 3,788 crore in FY23. The firm generates revenue by selling eyewear frames, lenses, goggles, and offering additional services such as eye check-ups. Due to cost-effective management, Lenskart reduced its losses by 84 per cent to Rs 10 crore in FY24 from Rs 63 crore in FY23. Lenskart continues to deepen its penetration in India while rapidly scaling its international presence, including in Southeast Asia and the Middle East. With a unique click-and-mortar business model, it is disrupting the eyewear industry by offering an omni-channel customer experience across online platforms, mobile applications, and stores. The company now has over 2,500 stores, of which 2,000 are in India. Globally and in India, Gurugram-based Lenskart competes with players such as Titan Eyeplus, Specsmakers, Vision Express, Warby Parker, and Italian eyewear conglomerate Luxottica Group. The company is also investing in manufacturing capabilities. It is planning to set up its largest eyewear manufacturing facility in Telangana with an investment of about Rs 1,500 crore. For this, it has signed a memorandum of understanding (MoU) with the Telangana government to establish the facility at Fab City. The smart glasses push positions Lenskart to compete in the emerging wearable technology market, as traditional eyewear companies face pressure to innovate beyond basic vision correction, analysts say.
Mint
14 minutes ago
- Mint
Jane Street Banned in India LIVE Updates: BSE, other capital market stocks take a hit; all you need to know
Jane Street Banned in India LIVE updates: SEBI, in its order on July 3, announced banning Jane Street, a US-based trading firm, from accessing the Indian stock market for allegedly manipulating the stock market through positions in India's booming derivatives trade. As per a PTI report, this could be the highest disgorgement amount ever directed by the Securities and Exchange Board of India (SEBI). What is Jane Street? Jane Street Group was established in 2000 as a global proprietary trading firm in the financial services industry. According to the company's website, it has more than 3000 employees across five global offices. We trade a broad range of asset classes on more than 200 venues in 45 countries. What did SEBI order say? In its interim order, the regulator has debarred JSI Investments, JSI2 Investments Pvt Ltd, Jane Street Singapore Pte Ltd, and Jane Street Asia Trading, entities collectively referred to as the Jane Street Group, from trading until further notice, while continuing its investigation. The Jane Street Group has come under Sebi's scrutiny for allegedly manipulating index levels in the stock market to earn illegal profits, primarily through the highly liquid Bank Nifty and Nifty index options segments. Follow updates here: 04 Jul 2025, 02:48 PM IST The capital market stocks fell today after SEBI barred US trading firm Jane Street from the Indian stock market over alleged manipulation in derivatives trading. Angel One slumped 6%. BSE share price was down 6.4% and Central Depository Services (India) fell 3.5%. Nuvama Wealth Management, which is Jane Street's India trading partner, fell more than 9%. 04 Jul 2025, 02:40 PM IST SEBI, in its 105-page order, accused Jane Street of manipulating the Bank Nifty index—an index made up of 12 top financial stocks and popular in derivatives trading. According to SEBI, Jane Street followed two key trading strategies over more than two years that were designed to unfairly move the index. Here's how it worked: In the morning, Jane Street would buy large amounts of Bank Nifty stocks and futures to artificially push up the index. At the same time, they were placing big bets against the index using options. Later in the day, they would reverse their trades—selling what they bought earlier—to drive the index back down and profit from the drop. SEBI said this created a false sense of market activity, tricking other traders into buying or selling at misleading price levels. On days when Bank Nifty options expired, Jane Street also made large, focused trades near market close, which SEBI says was an attempt to influence the final price of the index in their favour. 04 Jul 2025, 02:21 PM IST Market regulator banned US-based trading firm Jane Street from operating in the Indian stock market, accusing it of manipulating stock indices through its trades in the derivatives segment. In what is SEBI's toughest action yet against a foreign firm, the regulator said in an order on July 3 that Jane Street and its related companies are no longer allowed to trade in India. SEBI also seized ₹ 4,843 crore from the firm, calling it illegal profits made through the alleged manipulation.
